Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
4DMedical Ltd ( (AU:4DX) ) just unveiled an update.
4DMedical Ltd has applied to the ASX for quotation of 1,580,000 new fully paid ordinary shares, effective 24 December 2025. The securities arise from the exercise of options or conversion of other convertible instruments, modestly increasing the company’s share base and providing additional capital and liquidity to support its ongoing growth in the medical imaging market.
The most recent analyst rating on (AU:4DX) stock is a Hold with a A$3.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd, listed on the ASX under the code 4DX, operates in the medical technology sector, focusing on advanced imaging solutions for respiratory and pulmonary diagnostics. The company develops and commercialises software and imaging platforms aimed at improving the analysis and management of lung function for healthcare providers and patients.
Average Trading Volume: 5,128,041
Technical Sentiment Signal: Buy
Current Market Cap: A$1.84B
See more insights into 4DX stock on TipRanks’ Stock Analysis page.